Abiopharma

Charles River Laboratories Provides Update on Strategic Review

Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

MindMed to Participate in Upcoming Investor Conferences

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025

Insmed To Present at November and December 2025 Investor Conferences

Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference